Detalhe da pesquisa
1.
Management of patients with diffuse intrinsic pontine glioma in Australia and New Zealand: Australian and New Zealand Children's Haematology/Oncology Group position statement.
Med J Aust
; 220(10): 533-538, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38699949
2.
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy.
Br J Cancer
; 122(5): 680-691, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31919402
3.
Exploration of CTNNB1 ctDNA as a putative biomarker for hepatoblastoma.
Pediatr Blood Cancer
; 67(11): e28594, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32881242
4.
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
Lancet Oncol
; 19(6): 785-798, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29753700
5.
Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the "head-start" I and II clinical trials.
J Neurooncol
; 140(3): 717-725, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30392092
6.
Ub-ISAP: a streamlined UNIX pipeline for mining unique viral vector integration sites from next generation sequencing data.
BMC Bioinformatics
; 18(1): 305, 2017 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28623888
7.
Confirmation of Bevacizumab Activity, and Maintenance of Efficacy in Retreatment After Subsequent Relapse, in Pediatric Low-grade Glioma.
J Pediatr Hematol Oncol
; 37(6): e341-6, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26056795
8.
Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma.
Pediatr Blood Cancer
; 61(4): 601-5, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24504791
9.
A Phase 1 Study of Intravenous EGFR-ErbituxEDVsMIT in Children with Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor.
Target Oncol
; 19(3): 333-342, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38546944
10.
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
Nat Med
; 30(1): 207-217, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37978284
11.
Quantitative ctDNA Detection in Hepatoblastoma: Implications for Precision Medicine.
Cancers (Basel)
; 16(1)2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38201440
12.
BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experience.
Front Oncol
; 13: 1154246, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37124503
13.
Implementation of DNA Methylation Array Profiling in Pediatric Central Nervous System Tumors: The AIM BRAIN Project: An Australian and New Zealand Children's Haematology/Oncology Group Study.
J Mol Diagn
; 25(10): 709-728, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37517472
14.
ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.
Cancer Res
; 2023 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37145169
15.
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer.
Genome Med
; 15(1): 20, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37013636
16.
Extrarenal malignant rhabdoid tumor in childhood application of 18F-FDG PET/CT.
J Pediatr Hematol Oncol
; 34(1): 17-21, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22052165
17.
"We Have All This Knowledge to Give, So Use Us as a Resource": Partnering with Adolescent and Young Adult Cancer Survivors to Determine Consumer-Led Research Priorities.
J Adolesc Young Adult Oncol
; 11(2): 211-222, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297633
18.
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer.
EMBO Mol Med
; 14(4): e14608, 2022 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34927798
19.
Treatment of children with poor risk solid tumors by further escalation of the VETOPEC regimen including very high-dose cyclophosphamide and peripheral stem cell support: an Australian and New Zealand Children's Hematology and Oncology Group study.
Pediatr Blood Cancer
; 57(6): 958-64, 2011 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21793175
20.
Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumours.
Cancer Gene Ther
; 28(3-4): 321-334, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32873870